Navigation Links
ICU Medical Inc. and Health Robotics Announce Compatibility of CytoCare(TM) Robot and CLAVE(R) Needle-Free Connector to Enable Safer Hazardous Drug Handling

BOZEN and SUD TIROL, Italy, December 17 /PRNewswire/ -- Health Robotics and ICU Medical today announced the culmination of the development work both companies undertook to enable CytoCare(TM) customers to utilize the CLAVE(R) Needle-Free Connector around the world.

Based on customer demand, the companies entered into an agreement in mid-2008 to modify their respective products in order to enable the safe utilization of the CLAVE(R) Connector for the purpose of spiking IV Bags before their introduction into CytoCare(TM) for hazardous drug preparation and compounding. General availability of their combined compatible solutions is expected approximately in March 2009.

"We are very pleased to have worked with ICU Medical in the development of the first compatible needle-free connector to be utilized with our IV Robotic Solutions. This is especially important in the United States and Western Europe, where the demand for this combined solution encouraged us to quickly move in this direction. The CLAVE(R) was introduced in 1992 as the first one-piece, closed, needle-free connector and is currently the #1 connector sold worldwide. The CLAVE(R) is a mechanically and microbiologically closed system, which eliminates the risk of hazardous drug spills or leaks and also protects the patient's catheter from contamination that can otherwise lead to bloodstream infections," stated Werner Rainer, CEO of Health Robotics.

"Ever since our team visited the University of Colorado in Denver earlier this year and witnessed how CytoCare(TM) compounded chemotherapy IV medications, we realized that we were witnessing the future of hazardous drug compounding and decided to work with Health Robotics in meeting customers' demand for integrated solutions which meet the safety needs for both the Pharmacy and Nursing. We have had a long history of leading the market in providing solutions to improve the safety of healthcare workers and patients with IV Therapy and are also delighted to be the leader in needle-free connectors for Robotic drug preparation," stated George Lopez, MD, CEO ICU Medical.

"I am delighted to see ICU Medical and Health Robotics cooperate on the development of compatibility between CytoCare(TM) and a solution to spike the IV Hazardous Drugs Containers prior to preparation such as the CLAVE(R) Needle-Free Connector, so that we can simultaneously decrease the workload of our pharmacy technicians while protecting nursing personnel from unnecessary exposures to chemotherapy and other hazardous drugs. This will enable us to expand CytoCare(TM) utilization to all of our outpatient cancer care locations," stated Nancy Stolpman, Chief Pharmacist, University of Colorado Hospital.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing robots, providing health care facilities around the world with robotic technology and software automation solutions. The world-leading solutions CytoCare(TM) and i.v.STATION(TM) have and will greatly contribute to ease global pharmacies' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to decrease life-threatening medication errors and contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain spiraling costs.

About ICU Medical Inc.:

ICU Medical, Inc. is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications. Our devices are designed to protect patients from catheter related bloodstream infections and healthcare workers from exposure to hazardous drugs or infectious diseases through exposure to needles. We are also a leader in the production of custom I.V. systems and we incorporate our proprietary products into many of those custom I.V. systems.

    For additional information, please contact:

    Health Robotics
    Gaspar G. DeViedma
    USA: +1-609-980-7976
    Europe: +39-346-963-4934

    ICU Medical
    Scott Lamb
    USA: +1-949-366-2183

    Gabriele Giovanelli
    Europe: +39(0)44-257-0109

SOURCE Health Robotics SRL
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Maureen Mo Zilly Joins the Varian Medical Systems Government Affairs Team as Director, Federal Affairs
2. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
3. bwin and Harvard Medical School Faculty Sign 5-Year Research Cooperation Agreement
4. BioMS Medical recognized at Scrip Awards 2008
5. Oridion Announces Significant Medical Research to be Presented at AARC Congress
6. NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate
7. Life Science Alley: R&D Makes German Medical Technologies Top in Europe
8. ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis
9. China Sky One Medical, Inc. Interviewed in The China Perspective
10. Favrille and, Inc. Obtain Shareholder Approval to Move Forward With Merger
11. Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami
Post Your Comments:
(Date:11/27/2015)... Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... that it has closed the sale of its global ... (GBT- NYSE Euronext) in a transaction valued at approximately ... facilities and a total of approximately 1,000 employees spread ... St. Louis area. This entire workforce ...
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... 2015  Connected health pioneer, Joseph C. Kvedar ... technology-enabled health and wellness, and the business opportunities that ... The Internet of Healthy Things . Long before ... existed, Dr. Kvedar, vice president, Connected Health, Partners HealthCare, ... moving care from the hospital or doctor,s office into ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):